Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 8, 1996, Pages 983-995

  Tyagi, Suresh C ^a,b   Kumar, Suresh ^a,b   Cassatt, Shannah ^a,b   Parker, Janet L ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Angiogenesis; Collagen; Collagenase; Collateral; Development; Extracellular matrix; Gene expression; Ischemia; Matrix metalloproteinase; Occlusion; Plasminogen activator; Tissue inhibitor of metalloproteinase; Vasculogenesis

Indexed keywords

COLLAGEN; COLLAGENASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOG; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART INFARCTION; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLLAGENASES; COLLATERAL CIRCULATION; CORONARY DISEASE; DISEASE MODELS, ANIMAL; DOGS; ENZYME INDUCTION; EXTRACELLULAR MATRIX; GELATINASES; GLYCOPROTEINS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PHYSIOLOGIC; STAINING AND LABELING; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030449198     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-095     Document Type: Article

References (55)

1. Angus, J.A., Ward, J.E., Smolich, J.J., and McPherson, G.A. 1991. Reactivity of canine isolated epicardial collateral coronary arteries. Circ. Res. 69: 1340-1352.
2. Asahara, T., Bauters, C., and Zheng, L.P., Takenhita, S., Bunting, S., Symen, J.F., Inner, J.M., and Ferrara, N. 1995. Synergistic effect of VEGF and bFGF on angiogenesis in vivo. Circulation, 92: II365-II371.
3. Ausprunk, D.H., and Folkman, J. 1977. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis. Microvasc. Res. 14: 53-65.
4. Bradbury, P., and Gordon, K.C. 1982. Connective tissue and stains. In Theory and practice of histological techniques. Edited by J.D. Bancroft and A. Stevens. Churchill Livingstone, Edinburgh, London, Melborne, and New York. pp. 121-131.
5. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal. Biochem. 72: 248.
6. Burnette, W.N. 1981. "Western blotting": electrophoretic transfer of proteins from SDS-PAGE to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 195-203.
7. Carrell, R., and Travis, J. 1985. Alpha 1-antitrypsin and the serpins: variation and countervariation. Trends Biochem. Sci. 10: 20-24.
8. Carroll, S.M., White, F.C., Roth, D.M., and Bloor, C.M. 1993. Heparin accelarates coronary collateral development in a porcine model of coronary artery occlusion. Circulation, 88: 198-207.
9. Churgwin, J.M., Przybyla, A.Z., MacDonal, R.J., and Rutter, W.J. 1979. Isolation of biological active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 132: 613.
10. Folkman, J., and Klagsbrun, M. 1987. Angiogenic factors. Science (Washington, D.C.), 235: 442-448.
11. Folkman, J., Warson, K., Inger, D., and Hanahan, D. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (London), 339: 58-61.
12. Gerge, G., Schmidt, T., Ito, B., Pantely, G., and Schaper, W. 1989. Microvascular and collateral adaptation in swine hearts following progressive comary artery stenosis. Basic Res. Cardiol. 84: 524-535.
13. Gibbons, G.H., and Dzau, V.J. 1994. The emerging concept of vascular remodeling. N. Engl. J. Med. 330: 1431-1438.
14. Granelli-Piperno, A., and Reich, E. 1978. A study of protease and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148: 223-234.
15. Halperin, F., Thompson, K., and Rabinovitch, M. 1995. Elastase-mediated release of extracellular matrix-bound basic fibroblast growth factor: implications in coronary collateral development. Circulation, 92: 1-168.
16. Harrison, D.G., Chilian, W.M., and Marcus, M.L. 1986. Absence of functioning α-aderengic receptor in mature canine coronary collaterals. Circ. Res. 59: 133-142.
17. Iruela-Arispe, M.L., Diglio, C.A., and Sage, E.H. 1991. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler. Thromb. 11: 805-815.
18. Knoepfler, P.S., Bloor, C.M., and Carroll, S.M. 1995. Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion. J. Mol. Cell. Cardiol. 27: 1317-1324.
19. Ladoux, A., and Frelin, C. 1993. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195: 1005-1010.
20. 4. Nature (London), 227: 680.
21. Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336.
22. Madri, J.A., and Pratt, B.M. 1988. Molecular and cellular biology of wound repair. Edited by R.A.F. Clark and Pm.M. Henson. Plenum Press, New York. pp. 337-358.
23. Montesano, R. 1992. Regulation of angiogenesis in vitro. Eur. J. Clin. Invest. 22: 504-515.
24. Montesano, R., Vassalli, J.D., Baird, A., Guillemin, A., and Orci, L. 1986. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 83: 7297-7301.
25. Moscatalli, D., and Rifkin, D.B. 1988. Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim. Biophys. Acta, 948: 67-85.
26. Moses, M.A., and Langer, R. 1991. A metalloproteinase inhibitor as an inhibitor of neovascularization. J. Cell Biochem. 47: 230-235.
27. Moses, M.A., Sudhalter, J., and Langer, R. 1990. Identification of an inhibitor of neovascularization from cartilage. Science (Washington, D.C.), 248: 1408-1410.
28. Nikkari, ST., O'Brien, K.D., Ferguson, M., Hatsukami, T., Welgus, H.G., Alpers, C.E., and Clowes, A.W. 1995. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circ. Res. 92: 1393-1398.
29. Oho, S., Daley, S.J., Koo, E.W., Childs, T., Gotlieb, A.I., and Robinovitch, M. 1995. Increased elastin-degrading activity and neointimal formation in porcine aortic organ culture. Reduction of both features with a serine proteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15: 2200-2206.
30. Pasyk, S., Flameng, W., Wusten, B., and Schaper, W. 1976. Influence of tachycardia on regional myocardial flow in chronic experimental coronary occlusion. Basic Res. Cardiol. 71: 243-251.
31. Pasyk, S., Schaper, W., Schaper, J., Pasyk, K., Miskiewicz, G., and Steinseifer, B. 1982. DNA synthesis in coronary collaterals after artery occlusion in conscious dog. Am. J. Physiol. 242: H1031-H1037.
32. Peters, K.G., Marcus, M.L., and Harrison, D.G. 1989. Vasopressin and the mature coronary collateral circulation. Circulation, 79: 1324-1331.
33. Plate, K.H., Breier, G., Weich, H.A., and Risau, W. 1992. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vitro. Nature (London), 359: 845-848.
34. Pollane, J., Stephens, R.W., and Vaheri, A. 1991. Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res. 57: 273-328.
35. Rapps, J.A., Magliola, L., Jones, A.W., and Parker, J.L. 1993. Impaired endothelin-induced contraction in coronary collateral arteries. Circulation, 88: I-36.
36. Rapps, J.A., Zhong, Q., Myers, P.R., and Parker, J.L. 1994. Development of endothelium-dependent relaxation in canine coronary collateral arteries. Circulation, 90: I-459.
37. Reidy, M. A., Irvin, C., and Lindner, V. 1996. Migration of arterial wall cells: experiment of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78: 405-414.
38. Risau, W., and Ekblom, P. 1986. Growth factors and the embryonic kidney. In Progress in clinical and biological research, hormonal control of embryonic and cellular differentation. Edited by D. Serrero. Liss, New York.
39. Roberts, A.B., Spon, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefild, L.M., Heine, V., Liotta, L.A., Falanga, V., Kehrl, J.H., and Fauci, A.S. 1986. Transforming growth factor type β; rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83: 4167-4171.
40. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (London), 370: 61-65.
41. Schaper, W. 1991. Angiogenesis in the adult heart. Basic Res. Cardiol. 86: 51-56.
42. Schmidt, C.C., Georgescu, H.I., Kwoh, C.K., Blomstrom, G.L., Engle, C.P., Larkin, L.A., Evans, C.H., and Woo, S.L. 1995. Effect of growth factors on the proliferation of fibroblasts from the medial collateral and anterior cruciate ligaments. J. Orthop. Res. 13: 184-190.
43. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London), 359: 843-844.
44. Symes, J.F., and Sniderman, A.D. 1994. Angiogenesis: potential therapy for ischemic disease. Curr. Opin. Lipidol. 5: 305-312.
45. Tyagi, S.C., and Simon, S.R. 1993. Regulation of neutrophil elastase activity by elastin-derived peptide. J. Biol. Chem. 268: 16 513-16 518.
46. Tyagi, S.C., Matsubara, L., and Weber, K.T. 1993a. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin. Biochem. 26: 191-198.
47. Tyagi, S.C., Ratajska, A., and Weber, K.T. 1993b. Myocardial matrix metalloproteinase(s): activation and localization. Mol. Cell. Biochem. 126: 49-59.
48. Tyagi, S.C., Kumar, S.G., Banks, J., and Fortson, W. 1995a. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J. Mol. Cell. Cardiol. 27: 2177-2189.
49. Tyagi, S.C., Reddy, H.K., Campbell, S.E., and Weber, K.T. 1995b. Myocardial collagenase in failing human heart. In Wound healing in cardiovascular disease. Edited by K.T. Weber. Futura Publishing Co., Boston. pp. 67-72.
50. Tyagi, S.C., Meyer, L., Schmaltz, R.A., Reddy, H.K., and Voelker, D.J. 1995c. Proteinases and restenosis in human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis (Shannon, Irel.), 116: 43-57.
51. Tyagi, S.C., Kumar, S.G., and Glover, G. 1995d. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J. Cell Biochem. 58: 360-371.
52. Uchida, Y., Yanagisawa-Miwa, A., Ikuta, M., Makamura, F., Tomaru, T., Fujimori, Y., and Morita, T. 1994. Angiogenic therapy of acute myocardial infarction (AMI) by intrapericardial injection of basic fibroblast growth factor (bFGF) and heparin sulfate (HS): an experimental study. Circulation, 90(4, Part 2): I-296.
53. White, F.C., and Bloor, C.M. 1992. Coronary vascular remodeling and coronary resistance during chronic ischemia. Am. J. Cardiovasc. Pathol. 4: 193-202.
54. White, F.C., Carroll, S.M., Magnet, A., and Bloor, C.M. 1992. Coronary collateral development in the swine after coronary artery occlusion. Circ. Res. 71: 1490-1500.
55. Zou, Z., Anisowicz, A., Hendrix, M.J.C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. 1994. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Washington, D.C.), 263: 526-529.